I mmune disorders are characterized by excessive immune cell activation and aberrant inflammatory responses. Cell signals have been noted to regulate immune cell functions and to contribute to immune diseases, for example, upon extracellular stimulation, cell receptormediated signals, including mammalian target of rapamycin/signal transducer and activator of transcription factor 3 1,2 and mitogen-activated protein kinase/ nuclear factor-κB, 3, 4 induce the expression of proinflammatory cytokines and molecules, thereby resulting in immune cell activation and sustained inflammation, as seen in inflammatory bowel diseases and other immune disorders.
Beyond the active transcription of proinflammatory cytokines, posttranslational modifications have also been associated with inflammatory disorders. 5 Posttranslational modification by the inflammasome promotes the maturation and activation of proinflammatory cytokines, interleukin (IL)-1β and IL-18 in particular, leading to the exacerbation of immune diseases. 5 Recently, we noted that the inflammasome potentially mediates extracellular ATP/P2X7 receptordriven dextran sulfate sodium (DSS) colitis, 6 indicating the pivotal roles of the inflammasome in the regulation of immune responses in colitis.
Neddylation, another posttranslational modification, is mediated by the conjugation of neural-precursor-cell-expressed developmentally downregulated 8 (NEDD8) to the target proteins. 7 NEDD8 is initially activated by NEDD8-activating enzyme and is subsequently transferred to the E2 NEDD8-conjugating enzyme. This enzyme then conjugates NEDD8 to the substrate proteins, inclusive of Cullin-1. 7 Consequently, NEDD8 regulates conformational changes, by which it dominates the functions of the target proteins. 7 Intriguingly, neddylation has been reported to interact with and subsequently to regulate inflammasomedependent caspase-1 activation, 8 suggestive of the putative roles of neddylation in the modulation of posttranslational gene expression. Meanwhile, the neddylation process is noted to regulate multiple immune cell functions, 9,10 whereas its roles in the development of immune diseases remain to be elucidated.
To study the biofunctions of neddylation in immune disorders, we induced a DSS colitis model in BALB/c mice on day 1, according to the established protocol, with minor modifications, 6 that was approved by the Institutional Animal Care Committee at the hospital. In parallel, the mice were treated intraperitoneally with MLN4924, a first-in-class NEDD8-activating enzyme inhibitor, starting on day 3. On day 8, we determined the neddylation levels in the colon tissues of the mice by western blotting and noted that, in the neddylated fraction, Cullin-1 levels were induced in the colonic mucosa in mice with DSS colitis (Figure 1a) . Conversely, treatment with MLN4924 inhibited neddylation in the colon tissues of mice with colitis. The data indicate that neddylation occurs in the inflamed tissues of mice with DSS colitis and may be involved in the development of colitis.
Next, to further study the impacts of neddylation inhibition on DSS-induced colitis in mice, we determined multiple parameters of DSS colitis with or without MLN4924 treatment. DSS colitis in the mice was characterized by body weight loss, colitis symptoms, histological tissue damage and elevated proinflammatory cytokine production levels (Figures  1b-e) . Nevertheless, the mice with MLN4924 treatment regained their body weight (Figure 1b ) and had lower disease activity index scores (Figure 1c ) and histological scores (Figure 1d ) and reduced proinflammatory cytokine production levels (Figure 1e ) in their colon tissues. These data indicate that inhibition of neddylation by MLN4924 significantly ameliorates DSS-induced colitis.
In summary, neddylation may have putative roles in regulating immune responses and may contribute to the pathogenesis of inflammatory diseases, including colitis. The regulation of posttranslational modifications, including inflammasomes and neddylation, represents a new strategy for human immune disease treatment. Figure 1 Inhibition of neddylation protects mice against dextran sulfate sodium (DSS) colitis. BALB/c mice were fed distilled water containing 5% DSS to induce a colitis model starting on day 1 of the experiment, 6 and MLN4924 (15 mg/kg body weight) (DSS +MLN4924) or vehicle (DSS) was administered intraperitoneally to the mice daily from days 3 to 7. Control mice received distilled water only. (a) Proteins were extracted from colon tissues on day 8, and neddylation levels in the colon tissues of the mice were determined by western blotting. (b and c) Body weight changes and disease activity index (DAI) scores were recorded (n = 9). 6 (d) Hematoxylin and eosin staining was performed, and the histological scores in the colon tissues were graded on day 8 (n = 9). 6 (e) Tumor necrosis factor (TNF) levels in colonic homogenates of three groups of mice were determined by enzyme-linked immunosorbent assay (n = 9). The data are expressed as the means ± s.e.m. Significance was determined by a one-way analysis of variance using Tukey's post hoc test (*Po0.05, **Po0.01).
